Coronavirus Cure Update: AIIMS Patna to Start Clinical Trials of Covaxin, WHO claims Corona is Airborne

Finally, India will be soon stamping out its first-ever vaccine against coronavirus pandemic. According to the latest coronavirus news, ICMR (Indian Council of Medical Research) has developed India’s first native vaccine for coronavirus treatment with a joint partnership with Bharat Biotech. The name of the COVID-19 first-ever vaccines from India for the whole world is named: Covaxin. According to the latest news, it is also learned that soon the clinical trials will be conducted as a part of human trials of the indigenous COVID-19 vaccine (BBV152 COVID vaccine). 

As stated in the reports, AIIMS (All India Institute for Medical Sciences) Patna has been chosen among 12 other medical institutes across the nation to conduct the human trials and bring out positive coronavirus cure update. Further, it is also learned that the vaccine which is derived from the strain of SARS-Cov-2 isolated by ICMR-NIV, Pune, has shown better results regarding immunity and safety responses in preclinical studies.  

According to reliable sources, AIIMS Patna will be conducting the first indigenous human trials in the coming two days. This information was gathered from AIIMS Patna Superintendent Dr. CM Singh. This will be the first ever-trial that will be conducted in Patna on July 10 after completing certain formalities of logistics and mandatory processes. 

As stated by Dr. CM Singh, “Its Preclinical trials on animals have been successful. The results which have been received are encouraging. During the process, it has been seen that animals have developed immunity effectively. We’ll be following the protocol as guided by ICMR.” 

As stated in the coronavirus treatment update, Singh further adds that the clinical trial will be first conducted over 100 registered people that will further get increased in the second phase. Altogether, the duration of this clinical trial will take the next six-eight months to show its results. Further, he adds, as a coronavirus treatment the vaccine will be used on healthy people who are aging between 25-50 years (irrespective of the gender). 

As per the latest news, the ICMR has asked 12 selected cities to fasten the process of vaccine trails that are considered as the utmost important projects in the nation and also globally. Additionally, it is also defined by ICMR that these 12 selected institutes should be well defined with the expected results that the whole country wants to hear the latest by August 15. 

Followed by in another instance from the same field, the WHO (World Health Organization) has claimed that coronavirus in airborne disease. According to WHO’s Chief Scientist Dr. Soumya, Swaminathan, “Virus of COVID-19 can survive in the air and can get transmitted but in a very limited environment.”  

Amidst of coronavirus treatment, Dr. Swaminathan said that various water droplets in the air get present as we speak, shout, sing or breathe. These are normal droplets that fall on the ground within 1-2 meters. But, there are also smaller size droplets in the air that stay in the air for longer and take longer to settle down. These nano-droplets can move with the wind and thus have much potency to transfuse non-affected people in much less time. This form of transmission is called COVID-19 which is air-borne.

Additionally, technical lead on the Covid-19 pandemic at WHO Maria Van Kerkhove stated, “we have been talking about the possibility of airborne transmission and aerosol transmission as one of the modes of transmission of coronavirus.” She further adds, “The possibility of airborne transmission in a public setting-especially in very specific conditions, crowded poorly ventilated settings that have been described but cannot be ruled out.”